טוען...
Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells
Gemcitabine, a novel pyrimidine nucleoside analog, has become the standard chemotherapeutic agent for pancreatic cancer patients. The clinical impact of gemcitabine remains modest owing to the high degree of inherent and acquired resistance. There are various lines of evidence that confirm the role...
שמור ב:
| הוצא לאור ב: | Cell Mol Biol Lett |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SP Versita
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276009/ https://ncbi.nlm.nih.gov/pubmed/21225469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/s11658-010-0043-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|